Research and Markets: Idiopathic Pulmonary Fibrosis (IPF) - IPF Market to Hit ... Fort Mills Times With no fully-effective therapies other than lung transplantation, very little is understood about the heterogeneous nature of the disease, which has a disease course that further greatly varies between affected individuals. Dr. Samantha Fernando, The ... |
